Petr Cetkovský

1.4k total citations
71 papers, 870 citations indexed

About

Petr Cetkovský is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Petr Cetkovský has authored 71 papers receiving a total of 870 indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Hematology, 20 papers in Genetics and 15 papers in Molecular Biology. Recurrent topics in Petr Cetkovský's work include Acute Myeloid Leukemia Research (24 papers), Chronic Myeloid Leukemia Treatments (14 papers) and Acute Lymphoblastic Leukemia research (14 papers). Petr Cetkovský is often cited by papers focused on Acute Myeloid Leukemia Research (24 papers), Chronic Myeloid Leukemia Treatments (14 papers) and Acute Lymphoblastic Leukemia research (14 papers). Petr Cetkovský collaborates with scholars based in Czechia, Poland and Germany. Petr Cetkovský's co-authors include Petr Sedláček, Petra Cetkovská, Jana Marková, D Thouvenot, Sophie Dupuis‐Girod, Aloys C.M. Kroes, D Carrington, Marc Bierings, Florence Morfin and K Michalová and has published in prestigious journals such as Blood, PLoS ONE and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Petr Cetkovský

67 papers receiving 849 citations

Peers

Petr Cetkovský
C Ferry France
Mingzhe Han China
Luisa Strocchio Italy
Peter Johnson United Kingdom
Jaime Pérez de Oteyza Spain
Rémy Duléry France
Marie‐Thérèse Rubio France
Bernardino Allione Italy
Chun-Choo Kim South Korea
Mats Remberger Sweden
C Ferry France
Petr Cetkovský
Citations per year, relative to Petr Cetkovský Petr Cetkovský (= 1×) peers C Ferry

Countries citing papers authored by Petr Cetkovský

Since Specialization
Citations

This map shows the geographic impact of Petr Cetkovský's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petr Cetkovský with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petr Cetkovský more than expected).

Fields of papers citing papers by Petr Cetkovský

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petr Cetkovský. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petr Cetkovský. The network helps show where Petr Cetkovský may publish in the future.

Co-authorship network of co-authors of Petr Cetkovský

This figure shows the co-authorship network connecting the top 25 collaborators of Petr Cetkovský. A scholar is included among the top collaborators of Petr Cetkovský based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petr Cetkovský. Petr Cetkovský is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Vydra, Jan, Veronika Válková, Michal Kolář, et al.. (2019). Hematopoietic Stem Cell Transplantation From Haploidentical Donors in Aplasia After Cladribine/Cytarabine Chemotherapy for Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome. Clinical Lymphoma Myeloma & Leukemia. 19(6). 365–371. 1 indexed citations
3.
Vydra, Jan, Cyril Šálek, Jiřı́ Schwarz, et al.. (2017). Analysis of Real-world Data on Postremission Therapy for Acute Myeloid Leukemia With Intermediate Risk Cytogenetics in First Complete Remission. Clinical Lymphoma Myeloma & Leukemia. 18(2). 106–113. 2 indexed citations
4.
Salaj, Peter, Petr Cetkovský, Miroslav Penka, et al.. (2013). Economic evaluation of rFVIIa high initial dose compared to rFVIIa standard initial dose in patients with haemophilia with inhibitors using the Czech HemoRec registry. Thrombosis Research. 133(2). 162–167. 5 indexed citations
5.
Ráčil, Zdeněk, Martina Tošková, Iva Kocmanová, et al.. (2012). Micafungin as empirical antifungal therapy in hematological patients: a retrospective, multicenter study in the Czech and Slovak Republics. Leukemia & lymphoma. 54(5). 1042–1047. 5 indexed citations
6.
7.
Hubáček, Petr, et al.. (2012). Prevalence of chromosomally integrated HHV-6 in patients with malignant disease and healthy donors in the Czech Republic. Folia Microbiologica. 58(1). 87–90. 7 indexed citations
8.
Marková, Jana, Jana Březinová, K Michalová, et al.. (2011). Prognostic impact of DNMT3A mutations in patients with intermediate cytogenetic risk profile acute myeloid leukemia. European Journal Of Haematology. 88(2). 128–135. 58 indexed citations
9.
Pavlík, Tomáš, Eva Janoušová, Zdeněk Pospı́šil, et al.. (2011). Estimation of current cumulative incidence of leukaemia-free patients and current leukaemia-free survival in chronic myeloid leukaemia in the era of modern pharmacotherapy. BMC Medical Research Methodology. 11(1). 140–140. 4 indexed citations
10.
Šálek, Cyril, Jan Trka, Jan Vydra, et al.. (2010). [Treatment of adult acute lymphoblastic leukemia according to GMALL 07/2003 study protocol in the Czech Republic - the first experience].. PubMed. 56(3). 176–82. 7 indexed citations
11.
Žáčková, Daniela, Hana Klamová, Ladislav Dušek, et al.. (2010). Imatinib as the first‐line treatment of patients with chronic myeloid leukemia diagnosed in the chronic phase: Can we compare real life data to the results from clinical trials?. American Journal of Hematology. 86(3). 318–321. 12 indexed citations
12.
Doubek, Michael, Martin Brejcha, Zdeněk Pospı́šil, et al.. (2009). New prognostic markers of chronic lymphocytic leukemia in theeveryday hematological practice. A multicenter analysis.. 94.
13.
Klamová, Hana, et al.. (2009). Response to treatment in women with chronic myeloid leukemia during pregnancy and after delivery. Leukemia Research. 33(11). 1567–1569. 5 indexed citations
14.
Peková, Šoňa, Robert Ivánek, Michal Dvořák, et al.. (2009). Molecular variability of FLT3/ITD mutants and their impact on the differentiation program of 32D cells: Implications for the biological properties of AML blasts. Leukemia Research. 33(10). 1409–1416. 4 indexed citations
15.
Hubáček, Petr, A.C. Virgili Manrique, Katherine N. Ward, et al.. (2009). HHV‐6 DNA throughout the tissues of two stem cell transplant patients with chromosomally integrated HHV‐6 and fatal CMV pneumonitis. British Journal of Haematology. 145(3). 394–398. 33 indexed citations
16.
17.
Cetkovský, Petr, et al.. (2000). Causative factors for prolonged hospitalization beyond the point of engraftment in patients after autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation. 26(8). 877–880. 4 indexed citations
18.
Koza, Vladimír, et al.. (1998). Successful autologous transplantation in a patient with severe aplastic anemia (SAA). Bone Marrow Transplantation. 21(9). 957–959. 8 indexed citations
19.
Cetkovský, Petr, et al.. (1998). Successful treatment of severe Shulman’s syndrome by allogeneic bone marrow transplantation. Bone Marrow Transplantation. 21(6). 637–639. 23 indexed citations
20.
Cetkovský, Petr, et al.. (1997). Individual criteria could be optimal for starting G-CSF application after autologous stem cell transplantation. Bone Marrow Transplantation. 20(8). 639–641. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C Ferry Breakdown of academic impact, for papers by Mingzhe Han Breakdown of academic impact, for papers by Luisa Strocchio Breakdown of academic impact, for papers by Peter Johnson Breakdown of academic impact, for papers by Jaime Pérez de Oteyza Breakdown of academic impact, for papers by Rémy Duléry Breakdown of academic impact, for papers by Marie‐Thérèse Rubio Breakdown of academic impact, for papers by Bernardino Allione Breakdown of academic impact, for papers by Chun-Choo Kim Breakdown of academic impact, for papers by Mats Remberger
Rankless by CCL
2026